Acambis retained by Merrill at neutral

Acambis plc was retained by Merrill Lynch analyst Peter Welford at a neutral rating with a price target on the stock of 220p per share following a challenge filed by rival smallpox vaccine maker Bavarian Nordic relating to the U.S. government's stockpile contract. In London, Acambis shares Monday were down 5.57p, or 2.29%, at 245p on volume of 999,279 shares versus the three-month running average of 312,186 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.